Table 4.
Complications after balloon-occluded retrograde transvenous obliteration or transjugular intrahepatic portosystemic shunt
| Ref. |
LF
|
HE
|
Ascites
|
EVs aggravation
|
||||
|
BRTO
|
TIPS
|
BRTO
|
TIPS
|
BRTO
|
TIPS
|
BRTO
|
TIPS
|
|
| Choi et al[39] | 0/8 | 1/13 | 0/8 | 1/13 | 0/8 | 0/13 | 1/8 | 0/13 |
| Ninoi et al[40] | 3/771 | 10/271 | 0/77 | 5/27 | 6/77 | 14/77 | ||
| Sabri et al[41] | 0/23 | 0/27 | 0/23 | 6/27 | ||||
| Kim et al[42] | 0/25 | 0/27 | 0/25 | 6/27 | 1/25 | 1/27 | 1/25 | 0/27 |
| Lee et al[43] | 0/95 | 1/47 | 0/95 | 14/47 | 13/95 | 2/47 | ||
| Gimm et al[44] | 0/157 | 0/19 | 4/157 | 0/19 | 48/157 | 1/19 | 22/157 | 1/19 |
1
Including long-term events. BRTO: Balloon-occluded retrograde transvenous obliteration; TIPS: Transjugular intrahepatic portosystemic shunt; LF: Liver failure; HE: Hepatic encephalopathy; EVs: Esophageal varices.